Invesco S&P 500 Equal Weight Health Care ETF(RSPH · ETF)
ETF quote, holdings, sector allocation, technicals, and options analytics.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
Snapshot
$31.75
- 52-Week Range
- $27.33 – $33.51
- YTD
- -0.80%
- IV Rank (30D)
- 57.96
- Straddle Price
- $4.80
- P/C Vol Ratio
- 0.20
Info
Invesco S&P 500 Equal Weight Health Care ETF (RSPH) ETF
- Exchange
- ARCX
- Inception
- 2006-11-01
- Has Options
- Yes
ETF Profile
holdings as of 2026-06-07
Holdings
63
AUM
$643.4M
Provider
Invesco
Inception
2006-11-01
Exchange
ARCX
Data As Of
2026-06-07
Expense Ratio
—
Dividend Yield
0.71%
Distribution
Quarterly
Recent distributions
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| 2026-03-23 | 2026-03-27 | $0.0561 | CD |
| 2025-12-22 | 2025-12-26 | $0.0530 | CD |
| 2025-09-22 | 2025-09-26 | $0.0599 | CD |
| 2025-06-23 | 2025-06-27 | $0.0555 | CD |
| 2025-03-24 | 2025-03-28 | $0.0551 | CD |
| 2024-12-23 | 2024-12-27 | $0.0569 | CD |
Asset Allocation
Top Holdings
top 50 of 63 holdings
| Symbol | Name | Weight % | Asset Class | Country |
|---|---|---|---|---|
| HUM | Humana Inc | 3.41% | Equity (US) | — |
| CNC | Centene Corp | 2.89% | Equity (US) | — |
| ELV | Elevance Health Inc | 2.39% | Equity (US) | — |
| UNH | UnitedHealth Group Inc | 2.33% | Equity (US) | — |
| WST | West Pharmaceutical Services Inc | 2.20% | Equity (US) | — |
| CVS | CVS Health Corp | 2.11% | Equity (US) | — |
| DVA | DaVita Inc | 2.07% | Equity (US) | — |
| WAT | Waters Corp | 2.04% | Equity (US) | — |
| SOLV | Solventum Corp | 1.99% | Equity (US) | — |
| A | Agilent Technologies Inc | 1.95% | Equity (US) | — |
| VTRS | Viatris Inc | 1.91% | Equity (US) | — |
| LLY | Eli Lilly & Co | 1.90% | Equity (US) | — |
| CI | Cigna Group/The | 1.86% | Equity (US) | — |
| DXCM | Dexcom Inc | 1.83% | Equity (US) | — |
| RVTY | Revvity Inc | 1.83% | Equity (US) | — |
| INCY | Incyte Corp | 1.80% | Equity (US) | — |
| CRL | Charles River Laboratories International Inc | 1.79% | Equity (US) | — |
| BAX | Baxter International Inc | 1.79% | Equity (US) | — |
| VEEV | Veeva Systems Inc | 1.78% | Equity (US) | — |
| IQV | IQVIA Holdings Inc | 1.78% | Equity (US) | — |
| MRK | Merck & Co Inc | 1.73% | Equity (US) | — |
| BIIB | Biogen Inc | 1.71% | Equity (US) | — |
| HSIC | Henry Schein Inc | 1.69% | Equity (US) | — |
| EW | Edwards Lifesciences Corp | 1.68% | Equity (US) | — |
| DGX | Quest Diagnostics Inc | 1.66% | Equity (US) | — |
| ABBV | AbbVie Inc | 1.66% | Equity (US) | — |
| LH | Labcorp Holdings Inc | 1.63% | Equity (US) | — |
| PFE | Pfizer Inc | 1.62% | Equity (US) | — |
| TECH | Bio-Techne Corp | 1.61% | Equity (US) | — |
| JNJ | Johnson & Johnson | 1.60% | Equity (US) | — |
| ALGN | Align Technology Inc | 1.60% | Equity (US) | — |
| STE | STERIS PLC | 1.59% | Equity (US) | — |
| BMY | Bristol-Myers Squibb Co | 1.59% | Equity (US) | — |
| CAH | Cardinal Health Inc | 1.59% | Equity (US) | — |
| TMO | Thermo Fisher Scientific Inc | 1.58% | Equity (US) | — |
| MTD | Mettler-Toledo International Inc | 1.58% | Equity (US) | — |
| DHR | Danaher Corp | 1.57% | Equity (US) | — |
| IDXX | IDEXX Laboratories Inc | 1.55% | Equity (US) | — |
| ZBH | Zimmer Biomet Holdings Inc | 1.55% | Equity (US) | — |
| BDX | Becton Dickinson & Co | 1.54% | Equity (US) | — |
| AMGN | Amgen Inc | 1.54% | Equity (US) | — |
| MDT | Medtronic PLC | 1.53% | Equity (US) | — |
| COO | Cooper Cos Inc/The | 1.52% | Equity (US) | — |
| VRTX | Vertex Pharmaceuticals Inc | 1.51% | Equity (US) | — |
| GEHC | GE HealthCare Technologies Inc | 1.48% | Equity (US) | — |
| SYK | Stryker Corp | 1.47% | Equity (US) | — |
| GILD | Gilead Sciences Inc | 1.47% | Equity (US) | — |
| ISRG | Intuitive Surgical Inc | 1.42% | Equity (US) | — |
| MRNA | Moderna Inc | 1.41% | Equity (US) | — |
| ABT | Abbott Laboratories | 1.37% | Equity (US) | — |
Geographic Breakdown
Fund Holdings
Invesco S&P 500 Equal Weight Health Care ETF ·
NPORT-P period 2026-04-30
(filed 2026-03-30)
Net assets:
$759M
· 63 total positions
· equity 99.91%
· non-equity 2.46%
| # | Symbol | Issuer | Weight | Value |
|---|---|---|---|---|
| 1 | Moderna, Inc. | Moderna, Inc. | 2.48% | $18.9M |
| 2 | Gilead Sciences, Inc. | Gilead Sciences, Inc. | 1.91% | $14.5M |
| 3 | Merck & Co., Inc. | Merck & Co., Inc. | 1.85% | $14.0M |
| 4 | Viatris Inc. | Viatris Inc. | 1.85% | $14.0M |
| 5 | Centene Corp. | Centene Corp. | 1.83% | $13.9M |
| 6 | Molina Healthcare, Inc. | Molina Healthcare, Inc. | 1.83% | $13.9M |
| 7 | Johnson & Johnson | Johnson & Johnson | 1.80% | $13.7M |
| 8 | Baxter International Inc. | Baxter International Inc. | 1.80% | $13.7M |
| 9 | Cardinal Health, Inc. | Cardinal Health, Inc. | 1.77% | $13.5M |
| 10 | Amgen Inc. | Amgen Inc. | 1.77% | $13.5M |
| 11 | DexCom, Inc. | DexCom, Inc. | 1.77% | $13.4M |
| 12 | Charles River Laboratories International, Inc. | Charles River Laboratories International, Inc. | 1.77% | $13.4M |
| 13 | Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | 1.76% | $13.4M |
| 14 | Zoetis Inc. | Zoetis Inc. | 1.73% | $13.1M |
| 15 | Vertex Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | 1.73% | $13.1M |
| 16 | Bio-Techne Corp. | Bio-Techne Corp. | 1.72% | $13.1M |
| 17 | Cencora, Inc. | Cencora, Inc. | 1.72% | $13.1M |
| 18 | Revvity, Inc. | Revvity, Inc. | 1.72% | $13.1M |
| 19 | Incyte Corp. | Incyte Corp. | 1.72% | $13.1M |
| 20 | Stryker Corp. | Stryker Corp. | 1.71% | $13.0M |
| 21 | Eli Lilly and Co. | Eli Lilly and Co. | 1.71% | $13.0M |
| 22 | Cigna Group (The) | Cigna Group (The) | 1.71% | $13.0M |
| 23 | Quest Diagnostics Inc. | Quest Diagnostics Inc. | 1.70% | $12.9M |
| 24 | HCA Healthcare, Inc. | HCA Healthcare, Inc. | 1.70% | $12.9M |
| 25 | Labcorp Holdings Inc. | Labcorp Holdings Inc. | 1.70% | $12.9M |
Showing top 25 of 60 equity holdings.
Non-equity holdings
— 3 positions,
2.46% of NAV
| Category | Weight | Value | Positions |
|---|---|---|---|
| Short-term investment | 2.46% | $18.7M | 3 |
Daily issuer data also available
(2026-06-09)
via ETF Constituents
Price History
Seasonality
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +2.87% | 3 |
| Feb | +1.20% | 3 |
| Mar | -2.56% | 3 |
| Apr | -3.21% | 3 |
| May | +1.43% | 3 |
| Jun | +1.96% | 4 |
| Jul | +0.69% | 3 |
| Aug | +2.06% | 3 |
| Sep | -1.79% | 3 |
| Oct | -3.14% | 3 |
| Nov | +5.69% | 3 |
| Dec | +0.38% | 3 |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $30.87
SMA 50: $30.69
SMA 200: $31.04
Current: $31.74
EMA 12: $31.20
EMA 26: $30.96
MACD: 0.2407 | Signal: 0.1123
BULLISH
ADX (14): 15.94
RANGE
+DI: 31.78
−DI: 15.67
Momentum Oscillators
RSI (14): 63.56
NEUTRAL
Stoch %K: 84.45
Stoch %D: 78.29
Williams %R: -19.37
Volume & Volatility
BB Upper: $31.79
BB Lower: $29.95
NEUTRAL
OBV: -4,764,447
Vol SMA 20: 195,819
Vol ROC: 343.64%
ATR: $0.42
True Range: $0.23
HV 20: 16.0%
HV 30: 14.4%
HV 60: 15.1%
Data Summary
Data Points: 500
Last Updated: 2026-06-08T21:15:12.753000
Date Range: 2024-06-10T00:00:00 – 2026-06-08T00:00:00
AI Analysis
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
News
Options Activity
- IV Rank (30D)
- 57.96
- IV Rank (7D)
- 85.91
- Avg IV
- 50.1%
- Straddle (30D)
- $4.80
- Straddle (7D)
- $1.73
- P/C Volume
- 0.20
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Volatility Surface
Enter a ticker to render the implied volatility surface.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
- Beta (1Y vs SPY)
- 0.61
- Correlation (SPY)
- 47.3%
- R²
- 0.22
- Ann. Volatility
- 15.7%
- SPY Volatility
- 12.1%
Low volatility - stock moves less than market
Beta & Alpha Over Time
Constituent Performance
Click any bar to view the full quote for that stock.
Constituents
| Symbol | Price | 1 Day | 1 Week | 1 Month |
|---|